[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Ibrutinib  Market Research Report 2011-2023

April 2018 | 81 pages | ID: GB029B93805EN
HeyReport

US$ 1,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Summary

The global Ibrutinib  market will reach xxx Million USD in 2018 with CAGR xx% 2018-2023. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.

Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
  • 140 mg
  • 10 mg
  • 5 mg
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
  • Pharmacyclics, Inc.
  • Janssen Biotech, Inc.
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
  • Chronic Lymphocytic Leukaemia (CLL)
  • Mantle Cell Lymphoma (MCL)
  • Diffuse Large B Cell Lymphoma (DLBCL)
  • Multiple Myeloma (MM)
  • Follicular Lymphoma (FL)
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
  • Asia-Pacific
  • North America
  • Europe
  • South America
  • Middle East & Africa
1 MARKET OVERVIEW

1.1 Objectives of Research
  1.1.1 Definition
  1.1.2 Specifications
1.2 Market Segment
  1.2.1 by Type
    1.2.1.1 140 mg
    1.2.1.2 10 mg
    1.2.1.3 5 mg
  1.2.2 by Application
    1.2.2.1 Chronic Lymphocytic Leukaemia (CLL)
    1.2.2.2 Mantle Cell Lymphoma (MCL)
    1.2.2.3 Diffuse Large B Cell Lymphoma (DLBCL)
    1.2.2.4 Multiple Myeloma (MM)
    1.2.2.5 Follicular Lymphoma (FL)
  1.2.3 by Regions

2 INDUSTRY CHAIN

2.1 Industry Chain Structure
2.2 Upstream
2.3 Market
  2.3.1 SWOT
  2.3.2 Dynamics

3 ENVIRONMENTAL ANALYSIS

3.1 Policy
3.2 Economic
3.3 Technology
3.4 Market Entry

4 MARKET SEGMENTATION BY TYPE

4.1 Market Size
  4.1.1 140 mg Market, 2011-2016
  4.1.2 10 mg Market, 2011-2016
  4.1.3 5 mg Market, 2011-2016
4.2 Market Forecast
  4.2.1 140 mg Market Forecast, 2017-2022
  4.2.2 10 mg Market Forecast, 2017-2022
  4.2.3 5 mg Market Forecast, 2017-2022

5 MARKET SEGMENTATION BY APPLICATION

5.1 Market Size
  5.1.1 Chronic Lymphocytic Leukaemia (CLL) Market, 2011-2016
  5.1.2 Mantle Cell Lymphoma (MCL) Market, 2011-2016
  5.1.3 Diffuse Large B Cell Lymphoma (DLBCL) Market, 2011-2016
  5.1.4 Multiple Myeloma (MM) Market, 2011-2016
  5.1.5 Follicular Lymphoma (FL) Market, 2011-2016
5.2 Market Forecast
  5.2.1 Chronic Lymphocytic Leukaemia (CLL) Market Forecast, 2017-2022
  5.2.2 Mantle Cell Lymphoma (MCL) Market Forecast, 2017-2022
  5.2.3 Diffuse Large B Cell Lymphoma (DLBCL) Market Forecast, 2017-2022
  5.2.4 Multiple Myeloma (MM) Market Forecast, 2017-2022
  5.2.5 Follicular Lymphoma (FL) Market Forecast, 2017-2022

6 MARKET SEGMENTATION BY REGION

6.1 Market Size
  6.1.1 Asia-Pacific
    6.1.1.1 Asia-Pacific Market, 2011-2016
    6.1.1.2 Asia-Pacific Market by Type
    6.1.1.3 Asia-Pacific Market by Application
  6.1.2 North America
    6.1.2.1 North America Market, 2011-2016
    6.1.2.2 North America Market by Type
    6.1.2.3 North America Market by Application
  6.1.3 Europe
    6.1.3.1 Europe Market, 2011-2016
    6.1.3.2 Europe Market by Type
    6.1.3.3 Europe Market by Application
  6.1.4 South America
    6.1.4.1 South America Market, 2011-2016
    6.1.4.2 South America Market by Type
    6.1.4.3 South America Market by Application
  6.1.5 Middle East & Africa
    6.1.5.1 Middle East & Africa Market, 2011-2016
    6.1.5.2 Middle East & Africa Market by Type
    6.1.5.3 Middle East & Africa Market by Application
6.2 Market Forecast
  6.2.1 Asia-Pacific Market Forecast, 2017-2022
  6.2.2 North America Market Forecast, 2017-2022
  6.2.3 Europe Market Forecast, 2017-2022
  6.2.4 South America Market Forecast, 2017-2022
  6.2.5 Middle East & Africa Market Forecast, 2017-2022

7 MARKET COMPETITIVE

7.1 Global Market by Vendors
7.2 Market Concentration
7.3 Price & Factors
7.4 Marketing Channel

8 MAJOR VENDORS

8.1 Pharmacyclics, Inc.
  8.1.2 Profile
  8.1.2 Business Performance (Sales Revenue, Cost, Gross Margin)
8.2 Janssen Biotech, Inc.
  8.2.1 Profile
  8.2.2 Business Performance (Sales Revenue, Cost, Gross Margin)

9 CONCLUSION

LIST OF TABLES

Table Product Specifications of Ibrutinib
Table Products Segment of Ibrutinib
Table 140 mg Overview
Table 10 mg Overview
Table 5 mg Overview
Table Global Ibrutinib Market by Type, 2011-2022 (USD Million)
Table Application Segment of Ibrutinib
Table Chronic Lymphocytic Leukaemia (CLL) Overview
Table Mantle Cell Lymphoma (MCL) Overview
Table Diffuse Large B Cell Lymphoma (DLBCL) Overview
Table Multiple Myeloma (MM) Overview
Table Follicular Lymphoma (FL) Overview
Table Global Ibrutinib Market by Application, 2011-2022 (USD Million)
Table Global Ibrutinib Market by Region, 2011-2022 (USD Million)
Table Cost of Ibrutinib
Table Market Dynamics
Table Policy of Ibrutinib
Table GDP of Major Countries
Table 140 mg CAGR by Revenue and Volume, 2011-2016
Table 10 mg CAGR by Revenue and Volume, 2011-2016
Table 5 mg CAGR by Revenue and Volume, 2011-2016
Table 140 mg CAGR by Revenue and Volume, 2012-2022
Table 10 mg CAGR by Revenue and Volume, 2012-2022
Table 5 mg CAGR by Revenue and Volume, 2012-2022
Table Chronic Lymphocytic Leukaemia (CLL) CAGR by Revenue and Volume, 2011-2016
Table Mantle Cell Lymphoma (MCL) CAGR by Revenue and Volume, 2011-2016
Table Diffuse Large B Cell Lymphoma (DLBCL) CAGR by Revenue and Volume, 2011-2016
Table Multiple Myeloma (MM) CAGR by Revenue and Volume, 2011-2016
Table Follicular Lymphoma (FL) CAGR by Revenue and Volume, 2011-2016


LIST OF FIGURES

Figure Ibrutinib Picture
Figure Industry Chain Structure of Ibrutinib
Figure SWOT of Ibrutinib
Figure 140 mg Market Size and Growth, 2011-2016 (USD Million)
Figure 140 mg Market Size and Growth, 2011-2016 (in Volume)
Figure 10 mg Market Size and Growth, 2011-2016 (USD Million)
Figure 10 mg Market Size and Growth, 2011-2016 (in Volume)
Figure 5 mg Market Size and Growth, 2011-2016 (USD Million)
Figure 5 mg Market Size and Growth, 2011-2016 (in Volume)
Figure 140 mg Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 140 mg Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure 10 mg Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 10 mg Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure 5 mg Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure 5 mg Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Chronic Lymphocytic Leukaemia (CLL) Market Size and Growth, 2011-2016 (USD Million)
Figure Chronic Lymphocytic Leukaemia (CLL) Market Size and Growth, 2011-2016 (in Volume)
Figure Mantle Cell Lymphoma (MCL) Market Size and Growth, 2011-2016 (USD Million)
Figure Mantle Cell Lymphoma (MCL) Market Size and Growth, 2011-2016 (in Volume)
Figure Diffuse Large B Cell Lymphoma (DLBCL) Market Size and Growth, 2011-2016 (USD Million)
Figure Diffuse Large B Cell Lymphoma (DLBCL) Market Size and Growth, 2011-2016 (in Volume)
Figure Multiple Myeloma (MM) Market Size and Growth, 2011-2016 (USD Million)
Figure Multiple Myeloma (MM) Market Size and Growth, 2011-2016 (in Volume)
Figure Follicular Lymphoma (FL) Market Size and Growth, 2011-2016 (USD Million)
Figure Follicular Lymphoma (FL) Market Size and Growth, 2011-2016 (in Volume)
Figure Chronic Lymphocytic Leukaemia (CLL) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Chronic Lymphocytic Leukaemia (CLL) Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Mantle Cell Lymphoma (MCL) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Mantle Cell Lymphoma (MCL) Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Diffuse Large B Cell Lymphoma (DLBCL) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Diffuse Large B Cell Lymphoma (DLBCL) Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Multiple Myeloma (MM) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Multiple Myeloma (MM) Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Follicular Lymphoma (FL) Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Follicular Lymphoma (FL) Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2011-2016 (in Volume)
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
Figure North America Market Size and Growth, 2011-2016 (USD Million)
Figure North America Market Size and Growth, 2011-2016 (in Volume)
Figure North America Market Size by Type
Figure North America Market Share by Type
Figure North America Market Size by Application
Figure North America Market Share by Application
Figure Europe Market Size and Growth, 2011-2016 (USD Million)
Figure Europe Market Size and Growth, 2011-2016 (in Volume)
Figure Europe Market Size by Type
Figure Europe Market Share by Type
Figure Europe Market Size by Application
Figure Europe Market Share by Application
Figure South America Market Size and Growth, 2011-2016 (USD Million)
Figure South America Market Size and Growth, 2011-2016 (in Volume)
Figure South America Market Size by Type
Figure South America Market Share by Type
Figure South America Market Size by Application
Figure South America Market Share by Application
Figure Middle East & Africa Market Size and Growth, 2011-2016 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2011-2016 (in Volume)
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure North America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure North America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Europe Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Europe Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure South America Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure South America Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2017-2022 (in Volume)
Figure Ibrutinib Market Concentration by Region
Figure Marketing Channels Overview


More Publications